Gynecologic Cancer InterGroup

What Gynecologic Cancer InterGroup does

The Gynecologic Cancer InterGroup (GCIG) is described in its firmographic record as an organization that "aims to promote and facilitate quality clinical trials to improve outcomes for women with gynecologic cancer," implying a role as an international clinical-trial coordination consortium serving the gynecologic oncology research community. However, the scraped source material associated with the organization — the website at gciggroup.com — contains no content related to gynecologic cancer, clinical trials, oncology research, member institutions, or trial sponsors. Instead, the domain hosts a Swedish-language WordPress blog built on the ColorMag theme, publishing informational articles about home services including roofing (takläggare), kitchen renovation, moving services, floor sanding, moisture damage prevention, dental care, and address registration with Swedish authorities (Skatteverket). The site footer and legal metadata identify the operating entity as "Takläggare med ROT avdrag," and the geographic and regulatory references (Skatteverket, Personuppgiftslagen, ROT tax deduction) place the operational jurisdiction in Sweden. There is a clear identity-versus-content mismatch between the stated research mission and the actual web presence that any downstream user should weigh carefully.

No products, services, technology stack, pricing model, customer base, management team, funding rounds, or partnership network is disclosed for the organization in the source data. The website is a static content publication with no apparent monetization mechanism, no member portal, no trial registry integration, and no commercial offering. Operating status is active (copyright date 2026, recent article dates in 2023). No public listing, investor base, or corporate ownership structure is evidenced. As presented, the only observable business activity is the ongoing publication of Swedish home-services editorial content under a domain name that, by coincidence or repurposing, overlaps with the brand "Gynecologic Cancer InterGroup."

The mismatch between the stated clinical-trial coordination mission and the actual Swedish home-services blog footprint means the business model cannot be reliably characterized from the input. If the stated mission is accurate and the web presence is incidental or out of date, the organization would function as a non-commercial or membership-funded clinical-trial consortium; if the web presence reflects actual current activity, the entity operates as a Swedish affiliate-marketing or SEO content site unrelated to oncology. The source data does not resolve this ambiguity.

Name

Gynecologic Cancer InterGroup

Legal name

Takläggare med ROT avdrag

Website

https://gciggroup.com

Company type

Private

Operating status

Operating

Short description

According to its firmographic record, Gynecologic Cancer InterGroup aims to promote and facilitate quality clinical trials to improve outcomes for women with gynecologic cancer; however, the associated website (gciggroup.com) is a Swedish WordPress blog publishing home-services content, indicating an unresolved identity-versus-content mismatch.

Ownership category

akta.pro rank

Product category

Clinical Research

NAICS

Offices of Physicians (62111)

SIC

Services-Health Services (8000)

akta.pro primary industry

Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Gynecologic Oncology (HLAKAJAD)

Keywords

• Gynecologic cancer research
• Clinical trial coordination
• Oncology research collaboration
• Cancer clinical trials
• Gynecologic oncology studies

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

Gynecologic Cancer InterGroup aims to promote and facilitate quality clinical trials to improve outcomes for women with gynecologic cancer. The organization coordinates and supports collaborative oncology research across institutions involved in gynecologic cancer studies.

Differentiator

Problem solved

Functional benefit

Products and services

• Gynecologic Cancer Clinical Trials Coordination Coordination of clinical trials aimed at improving outcomes for women with gynecologic cancer, facilitating collaborative research among participating institutions and investigators.

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• NRG Oncology: One of the largest NCI-sponsored clinical trial cooperative groups in the U.S., formed from the merger of several oncology groups including the Gynecologic Oncology Group. Directly comparable as a multi-institutional gynecologic cancer trial coordinating organization.
• European Network of Gynaecological Oncological Trial Groups (ENGOT): A pan-European network coordinating gynecological cancer clinical trials across national groups. Directly comparable in mission and intergroup structure to the subject company.
• Gynecologic Cancer InterGroup (GCIG): An international collaboration of organizations performing gynecologic cancer clinical trials. Shares the subject company's name and exact stated mission, making it the most directly comparable entity; the data integrity issue with the subject's website domain heightens the relevance of this comparison.

Broad incumbents

• International Gynecologic Cancer Society (IGCS): Global professional society dedicated to gynecologic cancer research, education, and clinical trial promotion. Broader in scope than a trial cooperative but directly addresses the same patient population and research mission.
• National Cancer Institute (NCI): The U.S. federal agency leading the National Cancer Program and funding/coordinating a major share of oncology clinical trials. A structural incumbent and likely funding source or competitor for any gynecologic trial cooperative.
• Society of Gynecologic Oncology (SGO): U.S.-based professional society for healthcare professionals specializing in gynecologic oncology. Comparable as a stakeholder and convener in the gynecologic cancer research community, though not a trial cooperative itself.
• Cancer Research UK Clinical Trials Unit: One of the largest cancer research charities globally, running and funding clinical trials across multiple tumor types including gynecologic cancers. Comparable as a sponsor and coordinator of oncology clinical trials.

Emerging players

• Primo Pharma Partners: An emerging clinical research organization focused on women's health and oncology trials. Comparable as a smaller, more specialized CRO-style operator in adjacent oncology/women's-health trial coordination.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights2 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gynecologic Cancer InterGroup